Calcitonin gene-related peptide (CGRP) is an important neuropeptide in the pathogenesis of migraine. Whereas other neuropeptides in the trigeminal ......READ MORE
by David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN, FAHS; and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
A growing recognition of the differing pathophysiologic mechanisms involved in migraine is leading to more options for effective treatment than in ......READ MORE
by David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN, FAHS; and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Newer treatments have been developed to target important mechanisms in migraine pathophysiology. Recent arrivals to the migraine prevention space i......READ MORE
Acute medication overuse (AMO) is a serious risk for patients suffering from migraine headaches. Our featured expert discusses the overuse of acute......READ MORE
by David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN; and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
In addition to controlling the comorbidities and trigger factors that impact migraine, patients with difficult-to-treat migraine require effective ......READ MORE
by David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN; and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Novel therapies have led to much-needed advances in the preventive treatment of migraine. Our featured experts discuss clinical parameters and cons......READ MORE
